Body composition in lean women with polycystic ovary syndrome: Effect of ethinyl estradiol and drospirenone combination

Contraception

Volumn 87, Issue 3, 2013, Pages 358-362

  Aydin, Kadriye ^a   Cinar, Nese ^a   Aksoy, Duygu Yazgan ^a   Bozdag, Gurkan ^a   Yildiz, Bulent Okan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bioelectric impedance analysis; Body composition; Ethinyl estradiol drospirenone; Polycystic ovary syndome

Indexed keywords

ANDROGEN; DROSPIRENONE PLUS ETHINYLESTRADIOL; GLUCOSE; INSULIN; LIPID; SEX HORMONE BINDING GLOBULIN;

ADULT; ANDROGEN BLOOD LEVEL; BIOELECTRICAL IMPEDANCE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; IMPEDANCE; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MULTIPLE CYCLE TREATMENT; OVARY POLYCYSTIC DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; WAIST HIP RATIO;

ADOLESCENT; ADULT; ANDROSTENES; BODY COMPOSITION; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, COMBINED; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; POLYCYSTIC OVARY SYNDROME; THINNESS; YOUNG ADULT;

EID: 84873410291     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.07.005     Document Type: Conference Paper

References (24)

1. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 2004 2745 2749
2. S. Kirchengast, and J. Huber Body composition characteristics and fat distribution patterns in young infertile women Fertil Steril 81 2004 539 544
3. S. Kirchengast, and J. Huber Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome Hum Reprod 16 2001 1255 1260
4. C. Good, M. Tulchinsky, D. Mauger, L.M. Demers, and R.S. Legro Bone mineral density and body composition in lean women with polycystic ovary syndrome Fertil Steril 72 1999 21 25
5. A. Yucel, V. Noyan, and N. Sagsoz The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 126 2006 81 86
6. J. Vrbikova, and D. Cibula Combined oral contraceptives in the treatment of polycystic ovary syndrome Hum Reprod Update 11 2005 277 291
7. B.O. Yildiz Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment Semin Reprod Med 26 2008 111 120
8. R. Uras, M. Orru, and F. Pani Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome Contraception 82 2010 131 138
9. L. Ibanez, and F. de Zegher Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity J Clin Endocrinol Metab 89 2004 1592 1597
10. A. Kriplani, A.J. Periyasamy, and N. Agarwal Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome. Contraception 82 2010 139 146
11. E. Carmina, S. Bucchieri, and A. Esposito Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance J Clin Endocrinol Metab 92 2007 2500 2505
12. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
13. E. Carmina, F. Rosato, A. Janni, M. Rizzo, and R.A. Longo Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism J Clin Endocrinol Metab 91 2006 2 6
14. B.O. Yildiz, I.C. Haznedaroglu, S. Kirazli, and M. Bayraktar Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state J Clin Endocrinol Metab 87 2002 3871 3875
15. N. Cinar, M.C. Kizilarslanoglu, and A. Harmanci Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome Hum Reprod 26 2011 3339 3345
16. R. Pasquali, V. Vicennati, and A. Gambineri Influence of weight and distribution of adipose tissue in functional hyperandrogenism Contracept Fertil Sex 26 1998 372 375
17. J. Lord, R. Thomas, B. Fox, U. Acharya, and T. Wilkin The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome BJOG 113 2006 1203 1209
18. R. Horejsi, R. Moller, and S. Rackl Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women Am J Phys Anthropol 124 2004 275 281
19. Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. CD003987. (2006).
20. M. Guido, D. Romualdi, and M. Giuliani Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study J Clin Endocrinol Metab 89 2004 2817 2823
21. B.L. Heitmann Impedance: a valid method in assessment of body composition? Eur J Clin Nutr 48 1994 228 240
22. M. Bolanowski, and B.E. Nilsson Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis Med Sci Monit 7 2001 1029 1033
23. L.C. Ward, D. Doman, and S.A. Jebb Evaluation of a new bioelectrical impedance instrument for the prediction of body cell mass independently of height or weight Nutrition 16 2000 745 750
24. L.M. Browning, O. Mugridge, and A.K. Dixon Measuring abdominal adipose tissue: comparison of simpler methods with MRI Obes Facts 4 2011 9 15